Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
heart valves
MedTech
Abbott eyes structural heart gains after Boston Scientific exit
CEO Robert Ford said sales of its Navitor TAVR implant have doubled over the past two years, and that the road ahead looks favorable.
Conor Hale
Jul 17, 2025 1:00pm
Edwards highlights 8-year durability data for its Resilia valves
Apr 18, 2025 11:30am
Edwards nabs mitral valve startup Innovalve for $300M
Jul 15, 2024 10:30am
Edwards delivers 5-year TAVR safety data focused on women
Jun 6, 2024 2:05pm
Eko Health captures $41M to expand AI stethoscope business
Jun 6, 2024 12:00pm
Edwards excites with Evoque transcath tricuspid valve FDA nod
Feb 2, 2024 9:43am
